Best Practice & Research in Clinical Rheumatology

Papers
(The H4-Index of Best Practice & Research in Clinical Rheumatology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Role of diet in hyperuricemia and gout80
The epidemiology of psoriatic arthritis: A literature review58
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter44
Risk assessment tools for osteoporosis and fractures in 202241
The interplay between neutrophils, complement, and microthrombi in COVID-1935
Clinical features of psoriatic arthritis30
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes27
Managing patients using telerheumatology: Lessons from a pandemic27
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc25
Current status of imaging of Sjogren's syndrome24
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions23
Modifiable risk factors for bone health & fragility fractures23
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)21
Osteoporosis in 2022: Care gaps to screening and personalised medicine21
Current status of MR imaging of juvenile idiopathic arthritis20
Muscle imaging in myositis: MRI, US, and PET20
Contemporary imaging of rheumatoid arthritis: Clinical role of ultrasound and MRI19
Pathogenesis of calcium pyrophosphate deposition disease19
Imaging in the diagnosis and management of peripheral psoriatic arthritis18
The burden of osteoarthritis: Is it a rising problem?18
Treatment advances in gout18
Risk factors for osteoporosis and fractures in rheumatoid arthritis18
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon18
0.032193899154663